JP Morgan Chase’s Labcorp LH Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q3
– Sell
-25,000
Closed -$5.09M – 7564
2024
Q2
$5.09M Buy
+25,000
New +$5.09M ﹤0.01% 3022
2023
Q1
– Sell
-815
Closed -$165K – 7000
2022
Q4
$165K Buy
+815
New +$159K ﹤0.01% 5130
2016
Q4
– Sell
-233
Closed -$27K – 5071
2016
Q3
$27K Buy
+233
New +$27.5K ﹤0.01% 4141

Other funds holding LH

JP Morgan Chase's LH Position: Q2 2026 in Review

JP Morgan Chase reduced its Labcorp (LH) stake by 17% in Q2 2026, selling an estimated $69.5M and leaving 1,268,384 shares worth $355M. The position accounts for 0.02% of the portfolio, ranked #559.

JP Morgan Chase first reported a position in LH in Q2 2013 and has held it in 53 quarters since. The position peaked at $498M in Q4 2022. 1,060 funds tracked by Wall St. Rank hold LH as of Q2 2026.

  • JP Morgan Chase held 1,268,384 shares of Labcorp worth $355M as of Q2 2026.
  • JP Morgan Chase sold 264,339 Labcorp shares in Q2 2026, an estimated $69.5M.
  • Labcorp made up 0.02% of JP Morgan Chase's portfolio in Q2 2026, its #559 holding.
  • JP Morgan Chase first reported a position in Labcorp in Q2 2013 and has held it in 53 quarters since.
  • JP Morgan Chase's Labcorp position peaked at $498M in Q4 2022.
  • 1,060 funds tracked by Wall St. Rank held Labcorp as of Q2 2026.

Based on JP Morgan Chase's 13F filing for Q2 2026, filed 12 Aug 2026.